PDS Biotech Unveils New U.S. Patent For PDS0101 Technology
22 Jan 2026 //
GLOBENEWSWIRE
PDS Biotech Aligns With FDA On (PFS) As Primary Endpoint
09 Jan 2026 //
GLOBENEWSWIRE
PDS Biotech Secures New Patent For PDS0101 In Japan
09 Dec 2025 //
GLOBENEWSWIRE
PDS Biotech Announces Type C Meeting with the FDA
02 Dec 2025 //
GLOBENEWSWIRE
PDS Biotech Reports Q3 2025 Financials And Clinical Programs
13 Nov 2025 //
GLOBENEWSWIRE
PDS Biotech Reveals Strong Immunological Data For PDS0101
10 Nov 2025 //
GLOBENEWSWIRE
PDS Bio to Pursue Expedited Approval for PDS0101 in HPV16+ Cancer
29 Oct 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support